| EN
HKAPI AGM and Formation of the New Board

We are pleased to announce the formation of the HKAPI’s new Board (2026-28) following our Annual General Meeting on 26 March 2026.

Please join us in welcoming our newly elected Board members:

Ms Peggy Fung

PRESIDENT
General Manager
Hong Kong & Macau

Ms Kara Cheung

VICE PRESIDENT
General Manager
Board Members
Alphabetical listing by Surname

Ms. Andrea Chang

General Manager
Hong Kong & Macau

Ms. Priscilla Chau

General Manager
Hong Kong & Macau

Mr. Tony Cheng

General Manager

Mr. Donatas Grabliauskas

General Manager

Ms. Amy Ho

General Manager

Mr. Carvin Man

Senior General Manager
Sales & Marketing

Ms. Cecilia Qi

CEO

Mr. John Tan

Head of Hong Kong
SVP Novartis China

Mr. Nicholas Teo

General Manager

Honorary Treasurer will be nominated internally by the Board.

Congratulations to all our newly elected Board members as they take on their new roles and responsibilities. We are deeply grateful for their commitment to serving HKAPI, and we look forward to their leadership in driving the advancement of the pharmaceutical industry in Hong Kong.

Finally, we want to extend our heartfelt gratitude to the outgoing Board, project team and working group members who have served with such passion over the past two years. Your valuable contributions have been instrumental to our continued growth and success.

Newly elected Board members, Outgoing Board members, Legal Advisor and Senior Executive Director of the Association.
Close Bitnami banner
Bitnami